1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Marketing & Advertising

Strongest US Cough/Cold Season In 10 Years Likely

Sales Growth For US OTC Firms May Not Offset Inflation, Exchange Headwinds, Though

 
• By Malcolm Spicer

Increasing numbers cough/cold drug prescriptions combined with consumers’ waning interest in flu vaccines point to 2022-2023 season rivaling decade-high levels from 2017-18 and to retailers boosting inventories through year-end, Raymond James analysts say.

• Source: Shutterstock

The US consumer health product sector’s first results from the latest quarter could indicate the start of the strongest period in a decade for OTC cough/cold product sales, analysts at Raymond James suggest.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

ProBiotix Health Looks To Next Level In Korea’s $450m Probiotics Market

 
• By Tom Gallen

Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By Tom Gallen

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

Evidence Doesn’t Scratch Substantiation Itch In NAD Review Of MagniLife Gel Pain Relief Claims

 
• By Malcolm Spicer

National Advertising Division finds Magni Group didn’t support claims made on MagniLife Gel packaging, in direct-mail advertisements and online and in social media “Rapid Pain Relief.”

SFI Expands Distribution Of Brain Health Supplement In Europe

 
• By Tom Gallen

Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.

More from Business

Clasado Divests Bimuno Prebiotic Consumer Brand To UK’s Eleat

 
• By David Ridley

Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.

US Consumer Health Market People News: Kemin Loses Founder, BASF Corp. CEO, Bucked Up Rep

 
• By Malcolm Spicer

Kemin Industries founder, human and animal health care innovator RW Nelson dies; Heather Remley moves from BASF’s Global Engineering to North America business helm; and golfer Bryson DeChambeau links up with Bucked Up.

Givaudan Has UTI Health Claim Turned Down In EU

 
• By Tom Gallen

European Food Safety Authority finds no cause and effect relationship between Givaudan's Pacran supplement and defense against urinary tract infections.